CTBO (Cantabio Pharmaceuticals) Dividend Payout Ratio: 0.00 (As of Dec. 2018)


What is Cantabio Pharmaceuticals Dividend Payout Ratio?

Cantabio Pharmaceuticals CTBO Dividend Payout Ratio is 0.00 as of Dec. 2018.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Cantabio Pharmaceuticals's Dividend Payout Ratio for the months ended in Dec. 2018 was 0.00.

The historical rank and industry rank for Cantabio Pharmaceuticals's Dividend Payout Ratio or its related term are showing as below:


CTBO's Dividend Payout Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 0.445
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2026-06-26), the Dividend Yield % of Cantabio Pharmaceuticals is 0.00%.

Cantabio Pharmaceuticals's Dividends per Share for the months ended in Dec. 2018 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Cantabio Pharmaceuticals (OTCPK:CTBO) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Cantabio Pharmaceuticals Dividend Payout Ratio Related Terms

Cantabio Pharmaceuticals Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Cantabio Pharmaceuticals's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantabio Pharmaceuticals Dividend Payout Ratio Chart

Cantabio Pharmaceuticals Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Dividend Payout Ratio
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Cantabio Pharmaceuticals Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CTBO vs TNTY, ETNI, NTRR: Dividend Payout Ratio Comparison

For the Biotechnology subindustry, Cantabio Pharmaceuticals's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cantabio Pharmaceuticals Dividend Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cantabio Pharmaceuticals's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Cantabio Pharmaceuticals's Dividend Payout Ratio falls into.


Cantabio Pharmaceuticals Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Cantabio Pharmaceuticals's Dividend Payout Ratio for the fiscal year that ended in Mar. 2018 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Mar. 2018 )/ EPS without NRI (A: Mar. 2018 )
=0/ -343.047
=N/A

Cantabio Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Dec. 2018 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2018 )/ Earnings per Share (Diluted) (Q: Dec. 2018 )
=0/ 19.628
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.00 mean?
Cantabio Pharmaceuticals (CTBO) has a Dividend Payout Ratio of 0.00 as of Dec. 2018. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Cantabio Pharmaceuticals and its competitors.
Is Cantabio Pharmaceuticals' Dividend Payout Ratio too high?
Cantabio Pharmaceuticals' current Dividend Payout Ratio is 0.00.
How does Cantabio Pharmaceuticals' Dividend Payout Ratio compare to TNTY and ETNI?
Cantabio Pharmaceuticals' Dividend Payout Ratio of 0.00 can be compared against companies in the Biotechnology industry. The industry median Dividend Payout Ratio is 0.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Biotechnology company?
The median Dividend Payout Ratio among Biotechnology companies is 0.45, based on 134 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Cantabio Pharmaceuticals and its competitors. For the Biotechnology industry, the median Dividend Payout Ratio is 0.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cantabio Pharmaceuticals's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantabio Pharmaceuticals stock overvalued right now?
Cantabio Pharmaceuticals (CTBO) has a current Dividend Payout Ratio of 0.00. The current Dividend Payout Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Cantabio Pharmaceuticals (CTBO), the current Dividend Payout Ratio is 0.00 as of Dec. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantabio Pharmaceuticals Business Description

Address 1250 Oakmead Parkway, Sunnyvale, CA, USA, 94085
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.